John A. Borgeson

CFO John Borgeson sells 30,000 KOD shares for $1.0M under 10b5-1 plan as stock down -35.1% from 52-week high

John A. Borgeson, Chief Financial Officer, executed two separate sales on 2026-06-04 totaling 30,000 shares for $1,023,008.64, with a blended average price of $34.10. This sale reduces his non-derivative holdings from 241.9K to 211.9K shares (-12.4%). The transaction is part of a pre-arranged 10b5-1 trading plan adopted 2025-09-29, meaning it is scheduled rather than discretionary. At the current price of $31.05, the stock is -35.1% from its 52-week high and down -32.3% over the past 30 days. The company is unprofitable (net income -$58.2M over the most recent full fiscal year) and has a market cap of $1.9B. The CFO's prior sales at this same ticker show consistently positive 30-day returns (+12.3%, +9.1%, +7.5%, +5.2%) but negative 90-day returns (-12.7%, -15.2%, -16.4%, -18.2%), indicating a pattern where post-sale price momentum eventually reverses downward at this ticker.

CFO John A. Borgeson sells 30,000 shares of Kodiak Sciences (KOD) for $1,197,488.49 as stock up 53.7% in 30 days

John A. Borgeson, Chief Financial Officer of Kodiak Sciences, executed 4 separate sales totaling 30,000 shares for $1,197,488.49 on April 2, 2026, reducing his holdings from 213,316 shares to 183,316 shares (-14.1%). The sales occurred across a narrow price range ($39.14–$41.77, blended $39.92), following a 53.7% rally over the prior 30 days that brought the stock within 5.1% of its 52-week high of $42.81. The company remains unprofitable with full-year net income of $-61,457,000.00 against a $2.5B market cap. The CFO retains 183,316 shares post-transaction, maintaining a material stake; the execution is notable given the stock's sharp recent momentum and the company's negative profitability backdrop.